Medications for Addiction Treatment (MAT) of opioid use disorder involves a combination of medications that target the brain and psychosocial interventions (e.g., counseling, skills development) aimed at improving treatment outcomes. Research shows that medications and therapy together may be more successful than either treatment method alone.
Physicians must complete eight hours of training to apply to the DEA for a waiver to prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder. The American Osteopathic Academy of Addiction Medicine offers virtual training free of charge.
Register for an upcoming webinar here: https://education.aoaam.org/Waiver-training
MAOFP is once again joining together with MAFP for Family Medicine Advocacy Day. The event will take place virtually on March 23. Register now!
Stay tuned for details and registration.
2501 Jolly Road, Suite 110 | Okemos, MI 48864
517.253.8037 | fax: email@example.com